Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2021, Vol. 35 ›› Issue (1): 95-98.doi: 10.6040/j.issn.1673-3770.0.2020.227
Previous Articles Next Articles
PU Yadi1, LI Yuanbin2
CLC Number:
[1] Durand ML. Endophthalmitis[J]. Clin Microbiol Infect, 2013, 19(3):227-234. doi:10.1111/1469-0691.12118. [2] Baker AS, Okada AA, Johnson RP. Endogenous endophthalmitis[J]. Clin Infect Dis, 1994, 19(5):982. doi:10.1093/clinids/19.5.982. [3] Regan KA, Radhakrishnan NS, Hammer JD, et al. Endogenous Endophthalmitis: yield of the diagnostic evaluation[J]. BMC Ophthalmol, 2020, 20(1):138. doi:10.1186/s12886-020-01418-9. [4] Premathilake PNS, Kularatne WKS, Jayathilake JPK, et al. Klebsiella pneumoniae liver abscess: a case report[J]. J Med Case Rep, 2018, 12(1):367. doi:10.1186/s13256-018-1924-4. [5] 张自然, 孟凡征, 尹大龙, 等. 肺炎克雷伯菌性肝脓肿伴内源性眼内炎的诊断及治疗[J]. 中华肝脏外科手术学电子杂志, 2017, 6(6):433-436. doi:10.3877/cma.j.issn.2095-3232.2017.06.003 [6] Foo NP, Chen KT, Lin HJ, et al. Characteristics of pyogenic liver abscess patients with and without diabetes mellitus[J]. Am J Gastroenterol, 2010, 105(2):328-335. doi:10.1038/ajg.2009.586. [7] 范媛媛,魏文斌.内源性眼内炎新进展[J].国际眼科纵览,2018,42(5):329-337. doi:10.3760/cma.j.issn.1673-5803.2018.05.008. FAN Yuanyuan, WEI Wenbin. New advance on endogenous endophthalmitis[J]. International review of ophthalmology, 2018, 42(5):329-337. doi:10.3760/cma.j.issn.1673-5803.2018.05.008. [8] 陈薇,杨春凤,曹阳,等.肺炎克雷伯菌肝脓肿发病危险因素及致病菌耐药性分析[J].中华传染病杂志,2018,36(10):630-634. doi:10.3760/cma.j.issn.1000-6680.2018.10.011. [9] Fujita M, Takahashi A, Imaizumi H, et al. Endogenous endophthalmitis associated with pyogenic liver abscess caused by Klebsiella pneumoniae[J]. Intern Med, 2019, 58(17):2507-2514. doi:10.2169/internalmedicine.2684-19. [10] 唐旭园,童剑萍.内源性肺炎克雷伯杆菌性眼内炎的研究现状[J].中华眼视光学与视觉科学杂志,2017,19(5):317-320. doi:10.3760/cma.j.issn.1674-845X.2017.05.013. TANG Xuyuan, TONG Jianping. The research status of endogenous klebsiella endophthalmitis[J]. Chinese Journal of Optometry Ophthalmology and Visual Science, 2017, 19(5):317-320. doi:10.3760/cma.j.issn.1674-845X.2017.05.013. [11] Yang CS, Tsai HY, Sung CS, et al. Endogenous Klebsiella endophthalmitis associated with pyogenic liver abscess[J]. Ophthalmology, 2007, 114(5):876-880. doi:10.1016/j.ophtha.2006.12.035. [12] Sadiq MA, Hassan M, Agarwal A, et al. Endogenous endophthalmitis: diagnosis, management, and prognosis[J]. J Ophthalmic Inflamm Infect, 2015, 5(1):32. doi:10.1186/s12348-015-0063-y. [13] 王峰,陶勇,孙兵,等.肺炎克雷伯杆菌肺炎并发内源性眼内炎三例并文献复习[J].中华结核和呼吸杂志,2019,42(6):438-443. doi:10.3760/cma.j.issn.1001-0939.2019.06.007. WANG Feng, TAO Yong, SUN Bing, et al. Endogenous Klehsiella pneumoniae endophthalmifis associated witn Klebsiella pneumoniae pneumonia:3 cases report and literature review[J]. Chinese Journal of Tuberculosis and Respiratory Disease, 2019, 42(6):438-443. doi:10.3760/cma.j.issn.1001-0939.2019.06.007. [14] 吴柳,张洁,孙琳, 等.肺炎克雷伯菌肝脓肿70例临床分析[J].中国感染与化疗杂志,2018,18(1):11-17. doi:10.16718/j.1009-7708.2018.01.003. WU Liu, ZHANG Jie, SUN Lin, et al. Clinical characteristics of 70 cases of Klebsiella pneumoniae liver abscess[J]. Chinese Journal of Infection and Chemotherapy, 2018, 18(1):11-17. doi:10.16718/j.1009-7708.2018.01.003. [15] 周佳,沈玺.内源性肺炎克雷伯杆菌性眼内炎七例[J].中华眼底病杂志,2018,43(3):272-74. doi:10.3760/cma.j.issn.1005-1015.2018.03.015. [16] Chen YH, Li YH, Lin YJ, et al. Prognostic factors and visual outcomes of pyogenic liver abscess-related endogenous Klebsiella pneumoniae endophthalmitis: a 20-year retrospective review[J]. Sci Rep, 2019, 9(1):1071. doi:10.1038/s41598-018-37643-y. |
[1] | LI Shijin, TANG Angcang, YANG Bi, WANG Jianglan, LIU Longqian. Long-term effectiveness of virtual reality-based vision therapy for convergence insufficiency:a random clinical trial [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(5): 35-40. |
[2] | WANG MeiOverview,LI ZhihaiGuidance. Laryngeal cancer stem cells: potential therapeutic targets for overcoming multidrug resistance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(4): 120-128. |
[3] | WANG Huan, HU Li,YU Hongmeng. Research progress of olfactory dysfunction in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 43-49. |
[4] | PANG Chong, BIAN Sainan, ZHANG Bing, YIN Xu, LU Yingxia, YE Pengfei, WANG Zhan, ZHAO Jing, GAO Yan, GUAN Kai. Short-term effect of Dermatophagoides farinae specific sublingual immunotherapy for children with allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 70-74. |
[5] | LI Menghui, ZHI Lili, QI Kaiwen, WANG Shanshan, GAO Qian, BU Meiling,. Clinical research of subcutaneous immunotherapy on children with allergic asthma caused by dust mites and combined with mold allergen [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 75-80. |
[6] | LI Danyang,LIANG Hui. Advancements in orofacial myofunctional therapy for obstructive sleep apnea [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 108-114. |
[7] | WEI Ya'nan,CHEN Xi. Progress in chemotherapy and targeted drug therapy for locally advanced head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(3): 118-124. |
[8] | TAN Yufang, YI Tianhua. Clinical characteristics and prognosis of sudden sensorineural hearing loss in post-irradiated nasopharyngeal carcinoma survivors: a report of 18 cases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 35-39. |
[9] | FAN Li, LI Yue, XU Ximing. Changes in and prognostic value of the inflammatory index before and after concurrent chemoradiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 36-41. |
[10] | TAN Fengwu, DENG Yaping, LI Kehua. The therapeutic effects of low temperature plasma radiofrequency ablation and CO2 laser surgery on early glottic carcinoma: a Meta-analysis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 63-71. |
[11] | Vertigo is one of the most important symptom of peripheral vestibular diseases which are difficult to differentially diagnose and manage because multiple disciplines are involved. The premise of effective management is accurate diagnosis of vestibular diseases. With the development of vestibular function examination technology and the deepening of vestibular disease research, great progress has been made in the diagnosis and management of vestibular diseases. The establishment and publication of international classification of vestibular diseases, the introduction of diagnostic standards for various vestibular diseases in the world, the formulation of vestibular disease drugs, surgical specifications and the rapid development of vestibular rehabilitation technology make the diagnosis and management of vestibular diseases more and more standardized and accurate.. Diagnosis and management of peripheral vestibular diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 1-6. |
[12] | Central retinal artery occlusion(CRAO)is the most common cause of acute vision loss. Thrombolysis is a more radical treatment than conservative treatment, including arterial thrombolysis and intravenous thrombolysis, as well as the combination therapy of thrombolysis and other therapies. Thrombolysis treatment can improve the visual acuity of CRAO patients, but because of its lack of randomized controlled trials, further clinical studies are needed to determine their efficacy and safety. Our review summarized the application progress of thrombolysis in recent ten years, further evaluated its safety and effectiveness, and provided an evidence for clinical application.. Application progress of thrombolysis in retinal artery occlusionYANG Ming Overview WEI Wenbin Guidance Beijing Tongren Hospital, Capital Medical University / Beijing Tongren Eye Center / Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment / Beijing Ophthalmology&Visual Sciences Key Lab / Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing 100730, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 5-10. |
[13] | Ocular ischemic syndrome(OIS)is usually undiagnosed or misdiagnosed due to its asymptomatic onset, complicated ocular manifestations, and the lack of awareness, and patients with OIS have a higher mortality. Improving the understanding, diagnosis, and treatment of OIS through multidisciplinary collaboration is key to investigating and preventing systemic vascular events as well as decreasing blindness and mortality. This review summarizes the recent advances in the epidemiology, clinical diagnosis, and management of OIS.. Recent ocular ischemic syndrome advancesWANG Luping Overview HUANG Yingxiang, WANG Yanling Guidance Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract: [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 23-27. |
[14] | QING Xiaoyan, XU YiquanOverview, LI ChaoGuidance. Advances in molecular mechanisms of anaplastic thyroid cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(3): 26-31. |
[15] | ZHANG Jianli, CHEN Weixiong, CHEN Ruikai, KUANG Debing, PANG Yishi. Evaluation of the effect of fiberoptic endoscopic evaluation of swallowing on long-term survivor with nasopharyngeal cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 56-59. |
|